Study | Treatment success | Loss to follow-up | ||||||
Intervention arm | Comparison arm | Intervention group | Comparison group | |||||
Treatment success | Total sample | Treatment success | Total sample | LTFU | Total sample | LTFU | Total sample | |
Li et al11 | – | – | – | – | 3 | 172 | 12 | 26 |
Yin et al19 | 92 | 118 | 52 | 100 | – | – | – | – |
Oyieng'o et al39 | 6 | 8 | – | – | – | – | – | – |
Taneja et al40 | 20 | 32 | 14 | 38 | – | – | – | – |
Baral et al41 | 60 | 75 | 54 | 81 | 8 | 75 | 15 | 81 |
Brust et al42 | 59 | 80 | – | – | 4 | 80 | – | – |
Acha et al43 | 171 | 285 | – | – | 10 | 285 | – | – |
Mohr et al44 | 99 | 174 | 66 | 118 | 31 | 174 | 25 | 118 |
Sripad et al45 | – | – | – | – | 10 | 105 | 23 | 86 |
Bhatt et al46 | 39 | 60 | 29 | 63 | 3 | 60 | 15 | 63 |
DR-TB, drug-resistant tuberculosis; LTFU, lost to follow-up.